Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer-Reference-Cited by-同舟云学术

Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer

Published:2023-02-01 Issue:2 Volume:37 Page:225-232
ISSN:0892-7790
Container-title:Journal of Endourology
language:en
Short-container-title:Journal of Endourology

Author:

Dixon Christopher M.¹^ORCID,Levin Richard M.²,Cantrill Christopher H.³,Regelman Mikhail⁴,Spilseth Benjamin⁵,Tutrone Jr. Ronald F.²,White Michael A.³,Milbank Aaron J.⁴,Warlick Christopher A.⁵

Affiliation:

1. WMC Health Good Samaritan Hospital, Bon Secours Urology, Suffern, New York, USA.

2. Chesapeake Urology, Baltimore and Annapolis, Maryland, USA.

3. Urology San Antonio Research, San Antonio, Texas, USA.

4. Minnesota Urology, Woodbury, Minnesota, USA.

5. University of Minnesota, Departments of Urology and Radiology, Minneapolis, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Subject

Urology

Link

https://www.liebertpub.com/doi/pdf/10.1089/end.2022.0452

Reference12 articles.

1. Focal Ablation of Early-Stage Prostate Cancer

2. Targeting the cancer lesion, not the whole prostate

3. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters

4. Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting Tides: A Survey Analysis of Urologists' Evolving Attitudes and Practice Patterns in Focal Therapy for Prostate Cancer;2024-05-10